MicroRNAs as predictors for CNS relapse of systemic diffuse large B-cell lymphoma

Systemic diffuse large B-cell lymphoma (DLBCL) is a potentially curable disease using current regimen of immunochemotherapy. Central nervous system (CNS) relapse is a complication that occurs in approximately 5% of DLBCL patients and is associated with a high fatality rate. Early identification of m...

Descripción completa

Detalles Bibliográficos
Autores principales: Pillar, Nir, Bairey, Osnat, Goldschmidt, Neta, Fellig, Yakov, Rosenblat, Yevgenia, Shehtman, Itchak, Haguel, Danielle, Raanani, Pia, Shomron, Noam, Siegal, Tali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689664/
https://www.ncbi.nlm.nih.gov/pubmed/29156774
http://dx.doi.org/10.18632/oncotarget.20902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689664/
https://www.ncbi.nlm.nih.gov/pubmed/29156774
http://dx.doi.org/10.18632/oncotarget.20902

Ejemplares similares